VIENNA — Lexogen, a specialist in RNA sequencing technologies and next-generation sequencing services, announces the availability of designated NGS service workflows operated in compliance with the principles of the World Health Organization’s Good Clinical Laboratory Practice guidance. The offering is designed for clinical research and clinical-trial projects requiring enhanced controls for sample traceability, documentation, data integrity, technical review, and record retention. For […]
Jon Pratt brings more than 25 years of leadership experience, most recently as CEO of Filtration Group and previously at Waters, Beckman Coulter Life Sciences and Pall To assume CEO role on September 1, 2026, succeeding Thierry Bernard QIAGEN reaffirms outlook for the third quarter and full-year 2026; strategic review continues VENLO, Netherlands — QIAGEN […]
Biotech Fluidics announce SPEedy™ – a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample preparation procedures without need of an external vacuum and compatible with any adsorption chemistry or eluent composition. Small enough to fit in your lab coat pocket, yet so powerful it will accomplish complete SPE procedures within minutes. The innovative design […]
Veteran Pharmacogenomics Leader and Former St. Jude CEO to Guide BioSkryb’s Next Phase of Growth DURHAM, N.C. — BioSkryb Genomics, a pioneer in single-cell and ultra-low-input multiomic solutions, today announced that William E. Evans, Pharm.D., has been appointed as Chief Executive Officer. Dr. Evans has served on BioSkryb’s Board of Directors and as Chair of […]
Extension of the INDUCE-seq platform to support adenine base editing (ABE) workflows Researchers invited to gain early access to platform and support ongoing product development Cambridge, UK – Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today announced the launch of BaseMap™ ABE. Built on […]
The phenol-free magnetic bead workflow includes DNase treatment to optimize cfRNA recovery for downstream sequencing and amplification IPSWICH, Mass. — New England Biolabs (NEB®) announces the release of the Monarch Mag Cell-free RNA (cfRNA) Extraction Kit, which enables isolation of low-abundance, circulating cell-free RNA (cfRNA) and exome-associated RNA from biofluids including plasma, serum, urine and […]
Rainer Blair to retire WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced that the Company’s Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026. On that date, Rainer Blair will retire and serve as a […]
TORRANCE, CA, – Phenomenex Inc., a Danaher company and global leader in advanced technologies for the separation sciences, today announced the appointment of Dr. Lauryn Bailey as President of Phenomenex. Dr. Bailey joined Phenomenex in 2022 and has played an important role in advancing the company’s commercial and strategic priorities. “I’m honored to lead Phenomenex and […]
Eastern Institute of Technology professor recognized for advancing PFAS and emerging contaminant analysis SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced that the Eastern Institute of Technology, Ningbo has received an Agilent Research Catalyst (ARC) Award on behalf of Professor Zongwei Cai. The award recognizes Professor Cai’s innovative research focused on developing […]
Financing will help meet growing demand for faster PFAS data across field and laboratory workflows LONGMONT, Colo. — Biota Inc., an environmental diagnostics company developing faster technologies for per- and polyfluoroalkyl substances (PFAS) testing, today announced that it has closed a $3 million seed financing led by Burnt Island Ventures, with significant participation from DeepWork Capital. The […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
